Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Caladrius Biosciences Inc (NASDAQ:CLBS)

0.502
Delayed Data
As of 3:59pm ET
 +0.002 / +0.40%
Today’s Change
0.40
Today|||52-Week Range
2.03
-53.52%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues5.9M5.9M7.6M7.5M
 
 
 
 
 
Cost of Goods Sold5.2M4.2M5.5M5.6M
 
 
 
 
 
Depreciation And Amortization649.9K638.7K793.8K737.2K
 
 
 
 
 
 
Operating ExpensesGross Income-8.4K1.0M1.3M1.2M
 
 
 
 
 
General Expenses16.3M11.4M8.1M12.3M
 
 
 
 
 
Research And Development7.6M6.3M3.2M5.9M
 
 
 
 
 
Total Operating Expenses22.1M16.3M14.4M18.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.3M-10.4M-6.8M-11.1M
 
 
 
 
 
Extraordinary Credit5.4M0.00--0.00
 
 
Extraordinary Charge-9.4M-420.0K-52.9M0.00
 
 
 
 
Interest Expense On Debt547.3K553.0K477.0K926.8K
 
 
 
 
 
Other Expenses4.8K9.8K13.3M5.7K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.9M-11.3M-46.9M-12.0M
 
 
 
 
 
Income Taxes-3.7M-46.6K-13.6M-53.4K
 
 
 
 
 
Minority Interest-31.8K-16.9K-31.0K-66.9K
 
 
 
 
 
Net Income-17.1M-11.4M-33.2M-12.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS44.6M55.2M56.1M57.4M
 
 
 
 
 
Shares To Calculate EPS Diluted44.6M55.2M56.1M57.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.38-$0.21-$0.59-$0.21
 
 
 
 
 
EPS Diluted-$0.38-$0.21-$0.59-$0.21